Phibro Animal Health Corporation has grown revenue 11% a year over three years and 13% a year over five, with earnings per share compounding at 49%. Revenue growth, 3-year annual rate: +11% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +13%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +49%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 14, FY2012 to FY2025, as filed.

PAHCPhibro Animal Health Corporation

HealthcareUSD

$36.04

$27.7552 weeks$59.33

Is it growing?

Is PAHC growing?

Phibro Animal Health Corporation has grown revenue 11% a year over three years and 13% a year over five, with earnings per share compounding at 49%.

+11%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +11% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +49%
Earnings per share, 3-year rate · revenue +11% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed